Overview


According to FutureWise analysis, the market for Addison Disease Testing is expected to grow at a CAGR of 5.50% over the forecast period of 2023-2031.

Addison's disease is a rare condition characterized by inadequate secretion of the steroid hormone’s cortisol and aldosterone by the two layers of adrenal glands' cells. The signs of classic Addison's disease, also known as primary adrenal insufficiency, result in the insufficient secretion of these two hormones namely, cortisol and aldosterone. Significant symptoms include gastrointestinal abnormalities, fatigue, and changes in skin color. Behaviour and mood changes can also occur in some individuals with Addison's disorder. Increased excretion of water and low blood pressure can lead to dehydration. The symptoms of Addison's disease usually develop steadily but sometimes can develop rapidly; a severe condition called acute adrenal failure. In most cases, Addison's disease takes place when the body's immune system wrongly attacks the adrenal glands causing steadily progressive damage to the adrenal cortex.

A diagnosis of Addison's disease is suspected based on a clinical evaluation, a detailed patient history, and identification of characteristic findings. A diagnosis may be confirmed through various specialized tests, including the ACTH stimulation test, insulin-induced hypoglycaemia test, and x-ray examination. The ACTH stimulation test estimates the amount of cortisol in the blood. During this test, adrenocorticohormone (ACTH) is injected into the body, stimulating the production of cortisol. If the test fails to stimulate adequate cortisol production, it indicates that the adrenal glands are damaged or not functioning correctly.

FutureWise Market Research has published a report that provides an insightful analysis addison disease testing market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, addison disease testing market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

FutureWise Market Research has published a report that provides an insightful analysis addison disease testing market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

According to the analysis conducted by FutureWise research analysts, addison disease testing market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Diagnostic Laboratory Services, Inc.
  • Any Lab Test Now
  • Dr Lal PathLabs
  • Laboratory Corporation of America Holdings
  • Sonora Quest Laboratories
  • Core Diagnostics Private Limited
  • Ayumetrix

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Addison Disease Testing Market:

  • In April 2022- Diurnal Group extended its distribution agreement with Er-Kim to possess the distribution and marketing of Alkindi (hydrocortisone granules in capsules for opening) and Efmody (hydrocortisone modified-release hard pill) in Greece, Cyprus, and Malta.
  • In January 2022- Antares Pharma announced that the US Food and Drug Administration had granted Fast Track recognition for ATRS-1902 for adrenal crisis rescue in adults and adolescents using the company's Vai novel proprietary auto-injector platform to deliver a stable liquid formulation of hydrocortisone.

As the prevalence of Addison's disease rise, an increase in accurate and reliable testing methods and early diagnosis which is expected to boosts the growth of the target market. Addison's disease is treated with synthetic versions of the missing hormones, cortisol, and aldosterone. The common symptoms of Addison's disease are fatigue, abdominal pain, muscle weakness, and loss of appetite. Addison's disease is caused by autoimmune disease or sudden-stopping steroid medicines used to treat other conditions, further dominating the market in the forecast period. Early diagnosis of Addison's disease is crucial as it allows doctors to initiate life-saving treatment, preventing potentially life-threatening complications. Moreover, advancements in diagnostic technologies have significantly enhanced the accurate and efficient detection of Addison's disease. The most common tests used to diagnose Addison’s disease are the ACTH stimulation test, CRH stimulation test, CT scan, and MRI. The ACTH stimulation test is used most often to diagnose adrenal insufficiency. In this test, a healthcare professional will give you an IV injection of man-made ACTH like your body's ACTH. Healthcare specialists will take blood samples before and 30 or 60 mins after the injection. Then the cortisol levels in your blood samples are measured in the lab. Furthermore, the high cost of advanced diagnostic tests imposes significant barriers for patients, especially in developing nations with limited healthcare coverage and resources. The financial barrier may deter individuals from seeking timely diagnosis and delaying access to the treatment and care of Addison's disease. It may also affect the availability and accessibility of these tests in developing regions, hindering early detections and interventions.

By Testing Type

  • Laboratory Testing
  • Comprehensive Metabolic Panel
  • Thyroid-stimulating Hormone (Tsh) Levels
  • Acth Stimulation Test
  • Insulin-induced Hypoglycemia Test
  • Autoantibody Testing
  • Prolactin Testing
  • Imaging Studies
  • Chest Radiograph
  • Computed Tomography (Ct) Scan

By End User

  • Hospitals
  • Clinics
  • Diagnostics Laboratories

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Owing to the factors such as increasing disease instances in the region, growing demand for new generation technologically integrated advanced therapeutic drugs for swift and long-term therapy, and well-established healthcare infrastructure. According to the statistics published by (CDC) in 2021, it has been found that 35.8% of Non-Hispanic Asian persons, 29.7% of Hispanic people, and 11% of Non-Hispanic White people have tuberculosis disease in the United States. The increasing number of tuberculosis or adrenal tuberculosis cases causes adrenal insufficiency in patients by destructing the adrenal cortex and causing hypertrophy of the adrenal glands with caseating granulomas, thus, increasing the demand for better treatment in the region. Adrenal insufficiency also occurs due to direct glandular involvement, extra-adrenal infection, or anti-tuberculosis medication.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Addison Disease Testing Market By Testing Type, By End User and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Addison Disease Testing Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Addison Disease Testing Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Addison Disease Testing Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Addison Disease Testing Market, By Testing Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Laboratory Testing
        2. Comprehensive Metabolic Panel
        3. Thyroid-stimulating Hormone (Tsh) Levels
        4. Acth Stimulation Test
        5. Insulin-induced Hypoglycemia Test
        6. Autoantibody Testing
        7. Prolactin Testing
        8. Imaging Studies
        9. Chest Radiograph
        10. Computed Tomography (Ct) Scan

  • 8.   Addison Disease Testing Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories

  • 9.   North America Addison Disease Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Addison Disease Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Addison Disease Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Addison Disease Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Addison Disease Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •    1. Diagnostic Laboratory Services, Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Any Lab Test Now
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Dr Lal PathLabs
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Laboratory Corporation of America Holdings
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Sonora Quest Laboratories
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Core Diagnostics Private Limited
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Ayumetrix
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client

Related Market

Addison's Disease Treatment Market

Read More
Partner

Our Clients